Paul B Cleveland Insider Trading $ALDR ALDER BIOPHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul B Cleveland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul B Cleveland. Paul B Cleveland is Director in SANGAMO BIOSCIENCES INC ($SGMO) and EVP, Corp. Development and CFO in AFFYMAX INC ($AFFY) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Interim President and CEO in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Executive Officer in Adverum Biotechnologies, Inc. ($AAVL) and Director in Adverum Biotechnologies, Inc. ($ADVM) and President and CEO in Adverum Biotechnologies, Inc. ($AAVL).
Paul B Cleveland in ALDER BIOPHARMACEUTICALS INC
Trading Symbol: ALDRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul B Cleveland: Interim President and CEO, Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 24 2019
$ALDR Market Capitalization: $1.19B
$ALDR Previous Close: $23.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul B Cleveland in ALDER BIOPHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, AFFY, ALDR, SGMO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 11.95 | 100,000 | 1,195,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 32.76 | 17,300 | 566,748 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 38.54 | 12,700 | 489,458 | 0 | |
May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
Mar 27 2018 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Interim President a ... | Option Exercise | A | 11.95 | 100,000 | 1,195,000 | 100,000 | |
May 26 2017 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | A | 16.90 | 15,000 | 253,500 | 15,000 | |
Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
Oct 02 2015 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | A | 32.76 | 17,300 | 566,748 | 17,300 | |
Aug 27 2015 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | A | 38.54 | 12,700 | 489,458 | 12,700 |
Page: 1